Medication development and testing in children and adolescents: Current problems, future directions

Arts & Humanities

• Pediatrics 100%
• Medication 81%
• Psychopharmacology 50%
• Mental Health 49%
• Testing 48%
• Food and Drug Administration 43%
• Efficacy 34%
• Safety 33%
• Professional Associations 25%
• Health Professionals 22%
• Ethicists 20%
• Conducting 18%
• Clinicians 17%
• Drugs 15%
• Industry 6%

Medicine & Life Sciences

• Drug Development 69%
• Direction compound 52%
• National Institute of Mental Health (U.S.) 33%
• Psychopharmacology 33%
• Child 31%
• Pediatrics 31%
• United States Food and Drug Administration 24%
• Mental Health Associations 18%
• Ethicists 18%
• Research Personnel 16%
• Off-Label Use 16%
• Patient Advocacy 15%
• Safety 14%
• Congresses 12%
• Consensus 11%
• Industry 11%
• Pharmaceutical Preparations 5%